Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia

Published:2020-11 Issue:11 Volume:20 Page:e871-e882
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ravandi Farhad,Pierce Sherry^ORCID,Garcia-Manero Guillermo,Kadia Tapan,Jabbour Elias,Borthakur Gautam,DiNardo Courtney D.,Daver Naval,Short Nicholas J.^ORCID,Alvarado Yesid^ORCID,Cortes Jorge^ORCID,Kim Christopher,Kelsh Michael,Katz Aaron^ORCID,Williams Richard^ORCID,Yang Zhao,Mehta Bhakti,Kantarjian Hagop

Funder

Amgen

University of Texas MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. Relapsed acute myeloid leukemia: why is there no standard of care?;Ravandi;Best Pract Res Clin Haematol,2013

2. Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy;Weisberg;Onco Targets Ther,2018

3. Outcome of patients with acute myelogenous leukemia after second salvage therapy;Giles;Cancer,2005

4. Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies;Bertoli;Leuk Lymphoma,2019

5. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000;Kantarjian;Cancer,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy;2024-04-15

2. Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study;The Lancet Oncology;2024-03

3. Immune-related lncRNAs pairs prognostic score model for prediction of survival in acute myeloid leukemia patients;Clinical and Experimental Medicine;2023-05-26

4. Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome;Clinical Hematology International;2023-04-18

5. Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia;Leukemia Research;2022-11